Devonian Health Group Stock Performance
| GSD Stock | CAD 0.24 0.04 20.00% |
On a scale of 0 to 100, Devonian Health holds a performance score of 6. The firm shows a Beta (market volatility) of -1.26, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Devonian Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Devonian Health is expected to outperform it. Please check Devonian Health's value at risk and the relationship between the expected short fall and period momentum indicator , to make a quick decision on whether Devonian Health's price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Devonian Health Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Devonian Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:2 | Dividend Date 2017-05-19 | Last Split Date 2017-05-19 |
| Begin Period Cash Flow | 2.8 M |
Devonian |
Devonian Health Relative Risk vs. Return Landscape
If you would invest 16.00 in Devonian Health Group on September 13, 2024 and sell it today you would earn a total of 4.00 from holding Devonian Health Group or generate 25.0% return on investment over 90 days. Devonian Health Group is currently producing 0.9432% returns and takes up 11.1714% volatility of returns over 90 trading days. Put another way, 99% of traded stocks are less volatile than Devonian, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Devonian Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Devonian Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Devonian Health Group, and traders can use it to determine the average amount a Devonian Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0844
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GSD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.17 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.94 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Devonian Health is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Devonian Health by adding it to a well-diversified portfolio.
Devonian Health Fundamentals Growth
Devonian Stock prices reflect investors' perceptions of the future prospects and financial health of Devonian Health, and Devonian Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Devonian Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0812 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 22.03 M | ||||
| Shares Outstanding | 148.22 M | ||||
| Price To Book | 2.05 X | ||||
| Price To Sales | 3.04 X | ||||
| Revenue | 2.35 M | ||||
| Gross Profit | 561.01 K | ||||
| EBITDA | (2.46 M) | ||||
| Net Income | (4.6 M) | ||||
| Cash And Equivalents | 413.87 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 3.58 M | ||||
| Debt To Equity | 43.00 % | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (4.36 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Total Asset | 19.18 M | ||||
| Retained Earnings | (25.43 M) | ||||
About Devonian Health Performance
Evaluating Devonian Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Devonian Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Devonian Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. The company was incorporated in 2013 and is headquartered in Qubec, Canada. DEVONIAN HEALTH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.Things to note about Devonian Health Group performance evaluation
Checking the ongoing alerts about Devonian Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Devonian Health Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Devonian Health is way too risky over 90 days horizon | |
| Devonian Health has some characteristics of a very speculative penny stock | |
| Devonian Health appears to be risky and price may revert if volatility continues | |
| Devonian Health Group has accumulated 3.58 M in total debt with debt to equity ratio (D/E) of 43.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Devonian Health Group has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Devonian Health until it has trouble settling it off, either with new capital or with free cash flow. So, Devonian Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Devonian Health Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Devonian to invest in growth at high rates of return. When we think about Devonian Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.35 M. Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 561.01 K. | |
| Devonian Health Group has accumulated about 413.87 K in cash with (4.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of Devonian Health shares are held by company insiders |
- Analyzing Devonian Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Devonian Health's stock is overvalued or undervalued compared to its peers.
- Examining Devonian Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Devonian Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Devonian Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Devonian Health's stock. These opinions can provide insight into Devonian Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.